Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people... Read more »

AccentCare Names Chris Mayne President of Home Health

DALLAS--(BUSINESS WIRE)--AccentCare, a nationally recognized leader in post-acute health care, announces the... Read more »

knownwell Acquires Alfie Health

BOSTON--(BUSINESS WIRE)--knownwell, an in-person and virtual, weight-inclusive primary care and metabolic health... Read more »

Gain exposure through our multi-channel news platform.

Sun Pharma Completes Taro Merger with its Subsidiary

Dr. John E. Klibanoff Joins Auburn Orthopaedic Specialists

Omega Therapeutics Appoints Richard N. Kender to Board of Directors

Senseonics Holdings Provides Business Update

2024 PI Conference Underway in Chicago on June 20-22

Johnson & Johnson Completes Acquisition of Proteologix

Ascentage Pharma Closes $75 Million Equity Investment by Takeda

Riverpoint Medical, an Arlington Capital Partners Portfolio Company Acquires CP Medical

Tectonic Therapeutic Acquires AVROBIO

Phelps Lambert, M.D., of Greater Philly Opens MDVIP-Affiliated Primary Care Practice

NRx Pharmaceuticals to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024

Pearl Health CEO Michael Kopko Recognized as an EY Entrepreneur Of The Year 2024 New York Award Winner

IDB Bank Arranges $201.5 Million of Financing to Skilled Nursing Facilities

Regel Therapeutics Appoints Stephen J. Farr as Chief Executive Officer

Ratio Therapeutics Appoints William Cowan to its Board of Directors

Rapafusyn Pharmaceuticals Closes $28 Million Series A Financing